Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate eXoZymes, Inc. before investing.

In this article, we go over a few key elements for understanding eXoZymes, Inc.’s stock price such as:

• eXoZymes, Inc.’s current stock price and volume
• Why eXoZymes, Inc.’s stock price changed recently
• Upgrades and downgrades for EXOZ from analysts
• EXOZ’s stock price momentum as measured by its relative strength

About eXoZymes, Inc. (EXOZ)

Before we jump into eXoZymes, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Want to learn more about eXoZymes, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about eXoZymes, Inc..

eXoZymes, Inc.’s Stock Price as of Market Close

As of April 07, 2026, 3:43 PM, CST, eXoZymes, Inc.’s stock price was $10.010.

eXoZymes, Inc. is down 0.4% from its previous closing price of $10.050.

During the last market session, eXoZymes, Inc.’s stock traded between $9.500 and $11.540. Currently, there are approximately 8.39 million shares outstanding for eXoZymes, Inc..

eXoZymes, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

eXoZymes, Inc. Stock Price History

eXoZymes, Inc.’s (EXOZ) price is currently up 33.29% so far this month.

During the month of April, eXoZymes, Inc.’s stock price has reached a high of $11.540 and a low of $7.700.

Over the last year, eXoZymes, Inc. has hit prices as high as $18.400 and as low as $7.080. Year to date, eXoZymes, Inc.’s stock is down 8.17%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused eXoZymes, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 07, 2026, there were analysts who downgraded eXoZymes, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate eXoZymes, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on eXoZymes, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about eXoZymes, Inc. (EXOZ) by visiting AAII Stock Evaluator.

Relative Price Strength of eXoZymes, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 07, 2026, eXoZymes, Inc. has a weighted four-quarter relative price strength of -13.70%, which translates to a Momentum Score of 17 and is considered to be Very Weak.

Want to learn more about how eXoZymes, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

eXoZymes, Inc. Stock Price: Bottom Line

As of April 7, 2026, eXoZymes, Inc.’s stock price is $10.010, which is down 0.4% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like eXoZymes, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate eXoZymes, Inc. before investing.

In this article, we go over a few key elements for understanding eXoZymes, Inc.’s stock price such as:

• eXoZymes, Inc.’s current stock price and volume
• Why eXoZymes, Inc.’s stock price changed recently
• Upgrades and downgrades for EXOZ from analysts
• EXOZ’s stock price momentum as measured by its relative strength

About eXoZymes, Inc. (EXOZ)

Before we jump into eXoZymes, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Want to learn more about eXoZymes, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about eXoZymes, Inc..

eXoZymes, Inc.’s Stock Price as of Market Close

As of April 07, 2026, 3:43 PM, CST, eXoZymes, Inc.’s stock price was $10.010.

eXoZymes, Inc. is down 0.4% from its previous closing price of $10.050.

During the last market session, eXoZymes, Inc.’s stock traded between $9.500 and $11.540. Currently, there are approximately 8.39 million shares outstanding for eXoZymes, Inc..

eXoZymes, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

eXoZymes, Inc. Stock Price History

eXoZymes, Inc.’s (EXOZ) price is currently up 33.29% so far this month.

During the month of April, eXoZymes, Inc.’s stock price has reached a high of $11.540 and a low of $7.700.

Over the last year, eXoZymes, Inc. has hit prices as high as $18.400 and as low as $7.080. Year to date, eXoZymes, Inc.’s stock is down 8.17%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused eXoZymes, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 07, 2026, there were analysts who downgraded eXoZymes, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate eXoZymes, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on eXoZymes, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about eXoZymes, Inc. (EXOZ) by visiting AAII Stock Evaluator.

Relative Price Strength of eXoZymes, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 07, 2026, eXoZymes, Inc. has a weighted four-quarter relative price strength of -13.70%, which translates to a Momentum Score of 17 and is considered to be Very Weak.

Want to learn more about how eXoZymes, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

eXoZymes, Inc. Stock Price: Bottom Line

As of April 7, 2026, eXoZymes, Inc.’s stock price is $10.010, which is down 0.4% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like eXoZymes, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate eXoZymes, Inc. before investing.

In this article, we go over a few key elements for understanding eXoZymes, Inc.’s stock price such as:

• eXoZymes, Inc.’s current stock price and volume
• Why eXoZymes, Inc.’s stock price changed recently
• Upgrades and downgrades for EXOZ from analysts
• EXOZ’s stock price momentum as measured by its relative strength

About eXoZymes, Inc. (EXOZ)

Before we jump into eXoZymes, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Want to learn more about eXoZymes, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about eXoZymes, Inc..

eXoZymes, Inc.’s Stock Price as of Market Close

As of April 07, 2026, 3:43 PM, CST, eXoZymes, Inc.’s stock price was $10.010.

eXoZymes, Inc. is down 0.4% from its previous closing price of $10.050.

During the last market session, eXoZymes, Inc.’s stock traded between $9.500 and $11.540. Currently, there are approximately 8.39 million shares outstanding for eXoZymes, Inc..

eXoZymes, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

eXoZymes, Inc. Stock Price History

eXoZymes, Inc.’s (EXOZ) price is currently up 33.29% so far this month.

During the month of April, eXoZymes, Inc.’s stock price has reached a high of $11.540 and a low of $7.700.

Over the last year, eXoZymes, Inc. has hit prices as high as $18.400 and as low as $7.080. Year to date, eXoZymes, Inc.’s stock is down 8.17%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused eXoZymes, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 07, 2026, there were analysts who downgraded eXoZymes, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate eXoZymes, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on eXoZymes, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about eXoZymes, Inc. (EXOZ) by visiting AAII Stock Evaluator.

Relative Price Strength of eXoZymes, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 07, 2026, eXoZymes, Inc. has a weighted four-quarter relative price strength of -13.70%, which translates to a Momentum Score of 17 and is considered to be Very Weak.

Want to learn more about how eXoZymes, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

eXoZymes, Inc. Stock Price: Bottom Line

As of April 7, 2026, eXoZymes, Inc.’s stock price is $10.010, which is down 0.4% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like eXoZymes, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate eXoZymes, Inc. before investing.

In this article, we go over a few key elements for understanding eXoZymes, Inc.’s stock price such as:

• eXoZymes, Inc.’s current stock price and volume
• Why eXoZymes, Inc.’s stock price changed recently
• Upgrades and downgrades for EXOZ from analysts
• EXOZ’s stock price momentum as measured by its relative strength

About eXoZymes, Inc. (EXOZ)

Before we jump into eXoZymes, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Want to learn more about eXoZymes, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about eXoZymes, Inc..

eXoZymes, Inc.’s Stock Price as of Market Close

As of April 07, 2026, 3:43 PM, CST, eXoZymes, Inc.’s stock price was $10.010.

eXoZymes, Inc. is down 0.4% from its previous closing price of $10.050.

During the last market session, eXoZymes, Inc.’s stock traded between $9.500 and $11.540. Currently, there are approximately 8.39 million shares outstanding for eXoZymes, Inc..

eXoZymes, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

eXoZymes, Inc. Stock Price History

eXoZymes, Inc.’s (EXOZ) price is currently up 33.29% so far this month.

During the month of April, eXoZymes, Inc.’s stock price has reached a high of $11.540 and a low of $7.700.

Over the last year, eXoZymes, Inc. has hit prices as high as $18.400 and as low as $7.080. Year to date, eXoZymes, Inc.’s stock is down 8.17%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused eXoZymes, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 07, 2026, there were analysts who downgraded eXoZymes, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate eXoZymes, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on eXoZymes, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about eXoZymes, Inc. (EXOZ) by visiting AAII Stock Evaluator.

Relative Price Strength of eXoZymes, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 07, 2026, eXoZymes, Inc. has a weighted four-quarter relative price strength of -13.70%, which translates to a Momentum Score of 17 and is considered to be Very Weak.

Want to learn more about how eXoZymes, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

eXoZymes, Inc. Stock Price: Bottom Line

As of April 7, 2026, eXoZymes, Inc.’s stock price is $10.010, which is down 0.4% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like eXoZymes, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate eXoZymes, Inc. before investing.

In this article, we go over a few key elements for understanding eXoZymes, Inc.’s stock price such as:

• eXoZymes, Inc.’s current stock price and volume
• Why eXoZymes, Inc.’s stock price changed recently
• Upgrades and downgrades for EXOZ from analysts
• EXOZ’s stock price momentum as measured by its relative strength

About eXoZymes, Inc. (EXOZ)

Before we jump into eXoZymes, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Want to learn more about eXoZymes, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about eXoZymes, Inc..

eXoZymes, Inc.’s Stock Price as of Market Close

As of April 07, 2026, 3:43 PM, CST, eXoZymes, Inc.’s stock price was $10.010.

eXoZymes, Inc. is down 0.4% from its previous closing price of $10.050.

During the last market session, eXoZymes, Inc.’s stock traded between $9.500 and $11.540. Currently, there are approximately 8.39 million shares outstanding for eXoZymes, Inc..

eXoZymes, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

eXoZymes, Inc. Stock Price History

eXoZymes, Inc.’s (EXOZ) price is currently up 33.29% so far this month.

During the month of April, eXoZymes, Inc.’s stock price has reached a high of $11.540 and a low of $7.700.

Over the last year, eXoZymes, Inc. has hit prices as high as $18.400 and as low as $7.080. Year to date, eXoZymes, Inc.’s stock is down 8.17%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused eXoZymes, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 07, 2026, there were analysts who downgraded eXoZymes, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate eXoZymes, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on eXoZymes, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about eXoZymes, Inc. (EXOZ) by visiting AAII Stock Evaluator.

Relative Price Strength of eXoZymes, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 07, 2026, eXoZymes, Inc. has a weighted four-quarter relative price strength of -13.70%, which translates to a Momentum Score of 17 and is considered to be Very Weak.

Want to learn more about how eXoZymes, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

eXoZymes, Inc. Stock Price: Bottom Line

As of April 7, 2026, eXoZymes, Inc.’s stock price is $10.010, which is down 0.4% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like eXoZymes, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate eXoZymes, Inc. before investing.

In this article, we go over a few key elements for understanding eXoZymes, Inc.’s stock price such as:

• eXoZymes, Inc.’s current stock price and volume
• Why eXoZymes, Inc.’s stock price changed recently
• Upgrades and downgrades for EXOZ from analysts
• EXOZ’s stock price momentum as measured by its relative strength

About eXoZymes, Inc. (EXOZ)

Before we jump into eXoZymes, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Want to learn more about eXoZymes, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about eXoZymes, Inc..

eXoZymes, Inc.’s Stock Price as of Market Close

As of April 07, 2026, 3:43 PM, CST, eXoZymes, Inc.’s stock price was $10.010.

eXoZymes, Inc. is down 0.4% from its previous closing price of $10.050.

During the last market session, eXoZymes, Inc.’s stock traded between $9.500 and $11.540. Currently, there are approximately 8.39 million shares outstanding for eXoZymes, Inc..

eXoZymes, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

eXoZymes, Inc. Stock Price History

eXoZymes, Inc.’s (EXOZ) price is currently up 33.29% so far this month.

During the month of April, eXoZymes, Inc.’s stock price has reached a high of $11.540 and a low of $7.700.

Over the last year, eXoZymes, Inc. has hit prices as high as $18.400 and as low as $7.080. Year to date, eXoZymes, Inc.’s stock is down 8.17%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused eXoZymes, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 07, 2026, there were analysts who downgraded eXoZymes, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate eXoZymes, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on eXoZymes, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about eXoZymes, Inc. (EXOZ) by visiting AAII Stock Evaluator.

Relative Price Strength of eXoZymes, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 07, 2026, eXoZymes, Inc. has a weighted four-quarter relative price strength of -13.70%, which translates to a Momentum Score of 17 and is considered to be Very Weak.

Want to learn more about how eXoZymes, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

eXoZymes, Inc. Stock Price: Bottom Line

As of April 7, 2026, eXoZymes, Inc.’s stock price is $10.010, which is down 0.4% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like eXoZymes, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate eXoZymes, Inc. before investing.

In this article, we go over a few key elements for understanding eXoZymes, Inc.’s stock price such as:

• eXoZymes, Inc.’s current stock price and volume
• Why eXoZymes, Inc.’s stock price changed recently
• Upgrades and downgrades for EXOZ from analysts
• EXOZ’s stock price momentum as measured by its relative strength

About eXoZymes, Inc. (EXOZ)

Before we jump into eXoZymes, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Want to learn more about eXoZymes, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about eXoZymes, Inc..

eXoZymes, Inc.’s Stock Price as of Market Close

As of April 07, 2026, 3:43 PM, CST, eXoZymes, Inc.’s stock price was $10.010.

eXoZymes, Inc. is down 0.4% from its previous closing price of $10.050.

During the last market session, eXoZymes, Inc.’s stock traded between $9.500 and $11.540. Currently, there are approximately 8.39 million shares outstanding for eXoZymes, Inc..

eXoZymes, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

eXoZymes, Inc. Stock Price History

eXoZymes, Inc.’s (EXOZ) price is currently up 33.29% so far this month.

During the month of April, eXoZymes, Inc.’s stock price has reached a high of $11.540 and a low of $7.700.

Over the last year, eXoZymes, Inc. has hit prices as high as $18.400 and as low as $7.080. Year to date, eXoZymes, Inc.’s stock is down 8.17%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused eXoZymes, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 07, 2026, there were analysts who downgraded eXoZymes, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate eXoZymes, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on eXoZymes, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about eXoZymes, Inc. (EXOZ) by visiting AAII Stock Evaluator.

Relative Price Strength of eXoZymes, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 07, 2026, eXoZymes, Inc. has a weighted four-quarter relative price strength of -13.70%, which translates to a Momentum Score of 17 and is considered to be Very Weak.

Want to learn more about how eXoZymes, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

eXoZymes, Inc. Stock Price: Bottom Line

As of April 7, 2026, eXoZymes, Inc.’s stock price is $10.010, which is down 0.4% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like eXoZymes, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate eXoZymes, Inc. before investing.

In this article, we go over a few key elements for understanding eXoZymes, Inc.’s stock price such as:

• eXoZymes, Inc.’s current stock price and volume
• Why eXoZymes, Inc.’s stock price changed recently
• Upgrades and downgrades for EXOZ from analysts
• EXOZ’s stock price momentum as measured by its relative strength

About eXoZymes, Inc. (EXOZ)

Before we jump into eXoZymes, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Want to learn more about eXoZymes, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about eXoZymes, Inc..

eXoZymes, Inc.’s Stock Price as of Market Close

As of April 07, 2026, 3:43 PM, CST, eXoZymes, Inc.’s stock price was $10.010.

eXoZymes, Inc. is down 0.4% from its previous closing price of $10.050.

During the last market session, eXoZymes, Inc.’s stock traded between $9.500 and $11.540. Currently, there are approximately 8.39 million shares outstanding for eXoZymes, Inc..

eXoZymes, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

eXoZymes, Inc. Stock Price History

eXoZymes, Inc.’s (EXOZ) price is currently up 33.29% so far this month.

During the month of April, eXoZymes, Inc.’s stock price has reached a high of $11.540 and a low of $7.700.

Over the last year, eXoZymes, Inc. has hit prices as high as $18.400 and as low as $7.080. Year to date, eXoZymes, Inc.’s stock is down 8.17%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused eXoZymes, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 07, 2026, there were analysts who downgraded eXoZymes, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate eXoZymes, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on eXoZymes, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about eXoZymes, Inc. (EXOZ) by visiting AAII Stock Evaluator.

Relative Price Strength of eXoZymes, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 07, 2026, eXoZymes, Inc. has a weighted four-quarter relative price strength of -13.70%, which translates to a Momentum Score of 17 and is considered to be Very Weak.

Want to learn more about how eXoZymes, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

eXoZymes, Inc. Stock Price: Bottom Line

As of April 7, 2026, eXoZymes, Inc.’s stock price is $10.010, which is down 0.4% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like eXoZymes, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.